Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...

The t:slim X2 pump is currently cleared for use with Humalog and Novolog/NovoRapid U-100 insulins globally, and Admelog/Insulin lispro Sanofi and Trurapi/Insulin aspart Sanofi U-100 insulins in Canada ...

Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $45.42 which represents a slight increase of $0.79 or 1.77% from the prior close of $44.63. The stock opened at $45.17 and ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

View Tandem Diabetes Care, Inc. (TNDM) current and estimated P/E ratio data provided by Seeking Alpha.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

$ 45.00 0.37 0.83% ...

$ 44.80 0.17 0.38% ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Headlines,Tandem Diabetes Care shares saw a significant rise after a crucial EU approval for its insulin delivery system.,The ...